Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel F Dilling

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
The American Journal of Pathology|November 7, 2009
Melanoma-associated antigen expression in lymphangioleiomyomatosis renders tumor cells susceptible to cytotoxic T cellsJared Klarquist, Allison Barfuss, Sridhar Kandala, et al.
The American Journal of Pathology|May 14, 2013
Positioning ganglioside D3 as an immunotherapeutic target in lymphangioleiomyomatosisEmily R Gilbert, Jonathan M Eby, Adam M Hammer, et al.
Annals of the American Thoracic Society|February 11, 2020
Associations between Patient-reported Outcomes and Death or Lung Transplant in Idiopathic Pulmonary Fibrosis. Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes RegistryAmy Hajari Case, Anne S Hellkamp, Megan L Neely, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 13, 2022
Remote ex vivo lung perfusion at a centralized evaluation facilityJorge M Mallea, Matthew G Hartwig, Cesar A Keller, et al.
Chest|July 18, 2024
Unsupervised Exercise in Interstitial Lung Disease: A Delphi Study to Develop a Consensus Preparticipation Screening Tool for LymphangioleiomyomatosisClaire E Child, Lawrence A Ho, Daniel Lachant, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 31, 2024
A multidimensional classifier to support lung transplant referral in patients with pulmonary fibrosisJanelle Vu Pugashetti, John S Kim, Michael P Combs, et al.
Annals of the American Thoracic Society|June 2, 2017
A Phase II Clinical Trial of an Aromatase Inhibitor for Postmenopausal Women with LymphangioleiomyomatosisCalvin Lu, Hye-Seung Lee, George P Pappas, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 29, 2025
CD26/DPP-IV inhibitors and associations with chronic lung allograft dysfunction in a multicenter cohortAlexander R Graham, Maria V Grau-Sepulveda, Erika J Bush Buckley, et al.
Cancer Immunology, Immunotherapy : CII|October 28, 2016
Alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 can support immune responses toward tumors overexpressing ganglioside D3 in miceJonathan M Eby, Levi Barse, Steven W Henning, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 24, 2023
A randomized controlled trial of presatovir for respiratory syncytial virus after lung transplantJens Gottlieb, Fernando Torres, Tarik Haddad, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
The American Journal of Pathology|November 7, 2009
Melanoma-associated antigen expression in lymphangioleiomyomatosis renders tumor cells susceptible to cytotoxic T cellsJared Klarquist, Allison Barfuss, Sridhar Kandala, et al.
The American Journal of Pathology|May 14, 2013
Positioning ganglioside D3 as an immunotherapeutic target in lymphangioleiomyomatosisEmily R Gilbert, Jonathan M Eby, Adam M Hammer, et al.
Annals of the American Thoracic Society|February 11, 2020
Associations between Patient-reported Outcomes and Death or Lung Transplant in Idiopathic Pulmonary Fibrosis. Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes RegistryAmy Hajari Case, Anne S Hellkamp, Megan L Neely, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 13, 2022
Remote ex vivo lung perfusion at a centralized evaluation facilityJorge M Mallea, Matthew G Hartwig, Cesar A Keller, et al.
Chest|July 18, 2024
Unsupervised Exercise in Interstitial Lung Disease: A Delphi Study to Develop a Consensus Preparticipation Screening Tool for LymphangioleiomyomatosisClaire E Child, Lawrence A Ho, Daniel Lachant, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 31, 2024
A multidimensional classifier to support lung transplant referral in patients with pulmonary fibrosisJanelle Vu Pugashetti, John S Kim, Michael P Combs, et al.
Annals of the American Thoracic Society|June 2, 2017
A Phase II Clinical Trial of an Aromatase Inhibitor for Postmenopausal Women with LymphangioleiomyomatosisCalvin Lu, Hye-Seung Lee, George P Pappas, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 29, 2025
CD26/DPP-IV inhibitors and associations with chronic lung allograft dysfunction in a multicenter cohortAlexander R Graham, Maria V Grau-Sepulveda, Erika J Bush Buckley, et al.
Cancer Immunology, Immunotherapy : CII|October 28, 2016
Alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 can support immune responses toward tumors overexpressing ganglioside D3 in miceJonathan M Eby, Levi Barse, Steven W Henning, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 24, 2023
A randomized controlled trial of presatovir for respiratory syncytial virus after lung transplantJens Gottlieb, Fernando Torres, Tarik Haddad, et al.
Pageof 4